MAPK inhibitor shows promise in clinical trial for neuropathic pain

被引：11

|

作者：

Katie Kingwell

机构：

来源：

Nature Reviews Neurology | 2011年 / 7卷 / 7期

关键词：

D O I：

10.1038/nrneurol.2011.84

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：360 / 360

相关论文

共 50 条

[41] Dexpramipexole shows promise for ALS in phase II trial
Katie Kingwell
Nature Reviews Neurology, 2012, 8 (1) : 4 - 4
[42] Immunotherapy shows promise in Phase III neuroblastoma trial
Nature Reviews Drug Discovery, 2009, 8 : 604 - 604
[43] Trial shows promise for sublingual immunotherapy for peanut allergy
Patience, Jonny
EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2013, 9 (03) : 197 - 197
[44] Novel, synthetic molecule shows promise in preclinical trial
不详
EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (06) : 703 - 703
[45] TRIAL WATCH Integrin antagonist shows promise in MS
Crunkhorn, Sarah
NATURE REVIEWS DRUG DISCOVERY, 2012, 11 (03) : 178 - 178
[46] Smoked Medicinal Cannabis for Neuropathic Pain in HIV: A Randomized, Crossover Clinical Trial
Ellis, Ronald J.
Toperoff, Will
Vaida, Florin
van den Brande, Geoffrey
Gonzales, James
Gouaux, Ben
Bentley, Heather
Atkinson, J. Hampton
NEUROPSYCHOPHARMACOLOGY, 2009, 34 (03) : 672 - 680
[47] A Novel PKC Inhibitor Shows Promise for Amphetamine Use Disorders
Newman, Amy H.
NEUROPSYCHOPHARMACOLOGY, 2017, 42 (10) : 1929 - 1930
[48] A Novel PKC Inhibitor Shows Promise for Amphetamine Use Disorders
Amy H Newman
Neuropsychopharmacology, 2017, 42 : 1929 - 1930
[49] IL-23 inhibitor guselkumab shows promise for PsA
Jessica McHugh
Nature Reviews Rheumatology, 2020, 16 : 247 - 247
[50] Menin–KMT2A interaction inhibitor shows promise
David Killock
Nature Reviews Clinical Oncology, 2023, 20 : 284 - 284

← 1 2 3 4 5 →